ArticleSurgical endoscopy2025
Improvement in diastolic dysfunction after bariatric and metabolic surgery is associated with enhanced nitric oxide activity.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The effect of bariatric surgery on patient reported outcomes of heart failure in women: a pilot study.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionMetabolic and bariatric surgery (MBS) significantly improves diastolic dysfunction associated with heart failure with preserved ejection fraction (HFpEF), but the mechanism of improvement remains unknown. The purpose of this study was to explore whether sleeve gastrectomy (SG) in rodents improves diastolic dysfunction by enhancing nitric oxide (NO) signaling in a weight loss-independent manner.
methodsMale, C57BL/6 mice were fed a high-fat diet (HFD) or a low-fat diet (LFD) for ten weeks and were grouped into HFD fed obese SG (SG, n = 8), HFD obese pair-fed (to SG food intake) sham (SHPF, n = 9), HFD ad lib-fed obese sham (SH, n = 10), and lean ad lib LFD-fed (LEAN, n = 12) groups. Three months after undergoing SG or sham surgery, cardiac function, cardiac gene expression, urine nitrates/nitrites, and mesenteric resistance arterial (MRA) NO expression were compared between groups.
resultsPostoperatively, the SH group gained the most amount of weight compared to the SHPF and SG groups (24.25 vs 11.62 vs 10.14 g, respectively, p < 0.001). The SG cohort demonstrated optimal post-operative diastolic isovolumetric relaxation time compared to the SHPF and SH groups (isovolumetric relaxation time = 7.05 vs 9.74 vs 11.33 ms, p < 0.001). SG mice had increased urinary nitrates/nitrites secretion (p = 0.03) and increased cyclic guanosine monophosphate (cGMP) expression in cardiac tissue (p = 0.02) compared to the SHPF group.
conclusionSG improves diastolic function independent of weight loss in a mouse model of obesity and metabolic syndrome. The mechanism of improvement is associated with increased urinary nitrate/nitrite secretion, suggesting higher systemic levels of NO, and increased cGMP-mediated signaling in cardiac tissue. The ability of SG to beneficially alter NO-mediated signaling and improve diastolic dysfunction suggests a potential future role of MBS as a treatment for HFpEF.
Indexed as
Identifiers
40624425What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.